Prime Medicine, Inc. (PRME)
NASDAQ: PRME · Real-Time Price · USD
3.430
+0.250 (7.86%)
At close: Jun 26, 2026, 4:00 PM EDT
3.420
-0.010 (-0.29%)
After-hours: Jun 26, 2026, 7:08 PM EDT
Prime Medicine Market Cap
Prime Medicine has a market cap or net worth of $619.52 million as of June 26, 2026. Its market cap has increased by 216.78% in one year.
Market Cap
619.52M
Enterprise Value
598.53M
1-Year Change
216.78%
Ranking
Category
Stock Price
$3.43
Market Cap Chart
Since the IPO on October 20, 2022, Prime Medicine's market cap has decreased from $1.63B to $619.52M, a decrease of -61.93%. That is a compound annual growth rate of -23.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2026 | 619.52M | 0.85% |
| Dec 31, 2025 | 614.32M | 64.88% |
| Dec 31, 2024 | 372.58M | -54.41% |
| Dec 29, 2023 | 817.15M | -49.22% |
| Dec 30, 2022 | 1.61B | -1.12% |
| Oct 20, 2022 | 1.63B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Omeros | 627.49M |
| Eikon Therapeutics | 619.89M |
| Bright Minds Biosciences | 619.56M |
| Achieve Life Sciences | 618.01M |
| Crescent Biopharma | 616.73M |
| CorMedix | 615.85M |
| 4D Molecular Therapeutics | 606.40M |
| SL Science Holding | 606.09M |